MSB 1.34% $1.51 mesoblast limited

Another shakeout before move up?, page-74

  1. 4,001 Posts.
    lightbulb Created with Sketch. 315
    Once the various key p3 results (if positive) are out the market will move. Id rather management concentrate on these results. No announcement fluff pieces will suffice. I do believe we deserve better information without the fluff like some companies spew out. Comms could be better.

    "FDA conditional approval, expanded deal with our Japanese partner to sell too the world"
    I anticipate this, we do need it sooner rather than later. I wonder how the increase to 200 sites in Japan is going.

    I see the interim as a buying opportunity. If your style is to wait until proven, good on ya!!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.